Johnson & Johnson fourth-quarter sales up 1.7 percent, plans to divest diabetes care division

(Reuters) - Johnson & Johnson reported a 1.7 percent rise in fourth-quarter sales, due to a strong demand for its newer products.

Johnson & Johnson fourth-quarter sales up 1.7 percent, plans to divest diabetes care division
Read More


Bagikan Berita Ini